Related Experiment Video
Updated: Dec 27, 2025

08:30
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
13.5K
Adherence with Medical Therapy for Primary Open-Angle Glaucoma in Kenya - A Pilot Study
Ian Murdoch1, David Nyakundi2, Helen Baker1
1Institute of Ophthalmology, London EC1V 9EL, UK.
Patient Preference and Adherence
|February 28, 2020
Summary
Adherence to glaucoma eye drops is challenging in Africa. This pilot study used weighed bottles to objectively measure adherence, finding that while many patients struggled, those who returned for refills showed good compliance.
Area of Science:
- Ophthalmology
- Public Health
Background:
- Adherence to topical glaucoma therapy presents significant challenges, especially within the African healthcare context.
- Previous adherence assessments in this region have relied heavily on self-reporting, potentially overestimating compliance.
Purpose of the Study:
- To pilot an objective method for assessing medication adherence in patients with newly diagnosed open-angle glaucoma in an African setting.
- To evaluate the feasibility and preliminary findings of using weighed medication bottles to track adherence.
Main Methods:
- A pilot study involved 11 patients newly diagnosed with open-angle glaucoma who received Lumigan 0.01% in weighed bottles.
- Adherence was assessed over one year by weighing returned bottles monthly to estimate the number of drops used.
- A brief compliance questionnaire was administered alongside objective measurements.
Main Results:
- 45% of participants (5 out of 11) did not complete the full year of topical therapy.
- For the 6 patients who completed the year with monthly bottle returns and controlled intraocular pressure (IOP), the mean usage was 1.74 drops per eye per day.
- These adherent patients reported good self-perception of their compliance.
Conclusions:
- Objective adherence measures, alongside self-reports, suggest that topical medication may not be the optimal first-line treatment for glaucoma in this specific environment.
- The study highlights that patients consistently attending for repeat prescriptions and follow-up appointments demonstrate a higher likelihood of adherence.
Related Concept Videos
Open Angle Glaucoma: Treatment
900
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
900
Angle Closure Glaucoma: Treatment
1.0K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.0K
Glaucoma: Overview
1.1K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.1K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
173
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
173

